Overview

Hemophilia is a rare genetic bleeding disorder that impairs the body's ability to form blood clots, a critical process for stopping bleeding. People with hemophilia experience prolonged bleeding or oozing following an injury, surgery, or even spontaneously. This condition occurs due to a deficiency in specific clotting factors—proteins in the blood that control bleeding.

Types of Hemophilia

• Hemophilia A (Classic Hemophilia): Caused by a deficiency in clotting factor VIII. It is the most common type, affecting about 1 in 5,000 male births (CDC).
• Hemophilia B (Christmas Disease): Caused by a deficiency in clotting factor IX. It is less common, affecting about 1 in 25,000 male births (National Hemophilia Foundation).
• Hemophilia C: A mild form caused by a deficiency in clotting factor XI. It affects both males and females and is more common in people of Ashkenazi Jewish descent.

Who Does Hemophilia Affect?

Hemophilia primarily affects males because the genes responsible for clotting factors VIII and IX are located on the X chromosome. Males have one X and one Y chromosome (XY), so if the X chromosome carries the hemophilia gene, they will develop the disorder. Females have two X chromosomes (XX), so even if one X chromosome carries the gene, the other X chromosome can compensate. However, females can be carriers and may experience mild symptoms.

According to the World Health Organization (WHO), hemophilia occurs in about 1 in 10,000 births worldwide. It is estimated that more than 400,000 people globally live with hemophilia, though many remain undiagnosed, particularly in developing countries.

Symptoms

The severity of hemophilia symptoms depends on the level of clotting factors in the blood. Symptoms can range from mild to severe and may include:

Common Symptoms

• Excessive Bleeding: Prolonged bleeding from cuts, injuries, or after surgeries or dental procedures. Even minor cuts can bleed for a long time.
• Easy Bruising: Large, deep bruises may form from minor bumps or injuries. Bruises can also appear without any known cause.
• Spontaneous Bleeding: Bleeding that occurs without an obvious cause, such as nosebleeds or bleeding gums.
• Joint Bleeding (Hemarthrosis): Bleeding into joints, particularly the knees, elbows, and ankles, causing pain, swelling, and stiffness. Repeated joint bleeding can lead to chronic joint disease or arthritis.
• Muscle Bleeding: Bleeding into muscles, leading to swelling, pain, and stiffness. Large muscle bleeds can cause compartment syndrome, a serious condition that compresses nerves and blood vessels.
• Blood in Urine or Stool: Indicates bleeding in the kidneys, bladder, or digestive tract.
• Prolonged Bleeding After Vaccinations: Infants with hemophilia may bleed excessively after routine injections.
• Heavy Menstrual Bleeding: In female carriers, unusually heavy or prolonged menstrual periods may occur.

Symptoms by Severity

• Mild Hemophilia: Bleeding occurs mainly after significant injuries, surgeries, or dental procedures. Spontaneous bleeding is rare.
• Moderate Hemophilia: Bleeding occurs after minor injuries or spontaneously, but less frequently than in severe cases.
• Severe Hemophilia: Frequent spontaneous bleeding, often into joints and muscles, even without injury. This is the most common form, accounting for about 60% of hemophilia A cases (Mayo Clinic).

Causes and Risk Factors

Causes

Hemophilia is caused by mutations in the genes that provide instructions for making clotting factor proteins. These genes are located on the X chromosome:

• Hemophilia A: Caused by mutations in the F8 gene, which provides instructions for making factor VIII.
• Hemophilia B: Caused by mutations in the F9 gene, which provides instructions for making factor IX.

In about 30% of cases, hemophilia occurs due to a spontaneous mutation, meaning there is no family history of the disorder (NIH).

Inheritance Pattern

Hemophilia follows an X-linked recessive inheritance pattern:

• If a mother is a carrier (has one affected X chromosome), each of her sons has a 50% chance of inheriting the affected X chromosome and developing hemophilia.
• Each of her daughters has a 50% chance of inheriting the affected X chromosome and becoming a carrier.
• Fathers with hemophilia cannot pass the disorder to their sons (since they pass the Y chromosome), but all their daughters will be carriers.

Risk Factors

The primary risk factor for hemophilia is having a family history of the disorder. Other risk factors include:

• Being male (due to the X-linked inheritance pattern).
• Having a mother who is a known carrier of the hemophilia gene.
• In rare cases, acquiring hemophilia later in life due to the development of antibodies (inhibitors) that attack clotting factors. This is called acquired hemophilia and is not inherited.

Diagnosis

Hemophilia is typically diagnosed through a combination of medical history, physical examination, and blood tests. Early diagnosis is crucial for managing the condition effectively.

Diagnostic Tests

• Complete Blood Count (CBC): Measures the number of red blood cells, white blood cells, and platelets. While this test alone cannot diagnose hemophilia, it can help rule out other causes of bleeding.
• Activated Partial Thromboplastin Time (aPTT) Test: Measures how long it takes for blood to clot. Prolonged clotting time may indicate hemophilia A or B.
• Prothrombin Time (PT) Test: Measures clotting time for a different set of clotting factors. This test is usually normal in hemophilia.
• Factor Assays: Specific tests to measure the level and activity of factor VIII (for hemophilia A) or factor IX (for hemophilia B) in the blood. This confirms the diagnosis and determines the severity.
• Genetic Testing: Identifies the specific mutation in the F8 or F9 gene. This is useful for carrier testing and prenatal diagnosis.
• Inhibitor Tests: Checks for the presence of antibodies that may interfere with clotting factor treatment, particularly in patients who do not respond well to standard therapy.

Prenatal Diagnosis

If there is a family history of hemophilia, prenatal testing can be performed to determine if the fetus is affected. Tests include:

• Chorionic Villus Sampling (CVS): Performed at 10-12 weeks of pregnancy.
• Amniocentesis: Performed at 15-20 weeks of pregnancy.

These tests carry a small risk of miscarriage and should be discussed with a genetic counselor.

Treatment Options

While there is no cure for hemophilia, treatments are available to manage symptoms, prevent complications, and improve quality of life. Treatment focuses on replacing the missing clotting factor or using alternative therapies to promote clotting.

Clotting Factor Replacement Therapy

This is the primary treatment for hemophilia and involves infusing concentrated clotting factor into the bloodstream. There are two main types:

• Plasma-Derived Factors: Made from human blood plasma. These products are screened and treated to reduce the risk of transmitting infections.
• Recombinant Factors: Produced in a lab using genetically engineered cells. These are preferred because they do not carry the risk of transmitting bloodborne infections.

Treatment can be given:

• On-Demand: Used to treat bleeding episodes as they occur.
• Prophylactic (Preventive): Regular infusions (usually 2-3 times per week) to prevent bleeding episodes. This is common in severe hemophilia.

Other Medications

• Desmopressin (DDAVP): A synthetic hormone that stimulates the release of factor VIII. It is used for mild to moderate hemophilia A and can be given as an injection or nasal spray.
• Antifibrinolytic Agents: Medications like tranexamic acid or epsilon-aminocaproic acid help prevent the breakdown of blood clots. They are often used before dental procedures or for mouth/nose bleeds.
• Emicizumab (Hemlibra): A newer treatment for hemophilia A that mimics the function of factor VIII. It is given as a subcutaneous injection and can reduce the frequency of bleeding episodes.
• Gene Therapy: Emerging treatments aim to insert a corrected gene into the body to produce clotting factors. In 2022, the FDA approved etranacogene dezaparvovec (Hemgenix) for hemophilia B, the first gene therapy for hemophilia (FDA).

Treatment for Inhibitors

About 20-30% of people with severe hemophilia A develop inhibitors—antibodies that attack and neutralize clotting factors, making standard treatments less effective. Options for managing inhibitors include:

• Bypassing Agents: Medications like FEIBA (factor eight inhibitor bypassing activity) or NovoSeven (recombinant factor VIIa) that bypass the need for factor VIII or IX.
• Immune Tolerance Induction (ITI): A long-term treatment involving frequent, high-dose infusions of clotting factor to "retrain" the immune system to tolerate the factor.

Lifestyle and Home Remedies

• Avoid medications that can worsen bleeding, such as aspirin, ibuprofen, and other nonsteroidal anti-inflammatory drugs (NSAIDs). Acetaminophen (Tylenol) is a safer alternative for pain relief.
• Engage in regular, low-impact exercise (e.g., swimming, walking) to strengthen muscles and protect joints. Avoid contact sports like football or hockey.
• Maintain a healthy weight to reduce stress on joints.
• Use protective gear (e.g., helmets, knee pads) during physical activities.
• Practice good dental hygiene to prevent gum disease and reduce the risk of bleeding.

Living with Hemophilia

With proper management, people with hemophilia can lead active, fulfilling lives. Here are some practical tips for daily living:

Self-Care Tips

• Learn to Recognize Bleeding Early: Early treatment can prevent complications. Signs of internal bleeding include pain, swelling, warmth, or stiffness in joints/muscles.
• Carry Medical Identification: Wear a medical alert bracelet or carry a card indicating you have hemophilia, your blood type, and emergency contact information.
• Keep a Treatment Log: Track bleeding episodes, treatments, and responses to help your healthcare team adjust your care plan.
• Educate Family and Friends: Teach those close to you how to recognize bleeding episodes and administer first aid or clotting factor if needed.
• Travel Prepared: Carry enough clotting factor for your trip, along with a letter from your doctor explaining your condition. Research hemophilia treatment centers at your destination.

Diet and Nutrition

While diet cannot cure hemophilia, a balanced diet supports overall health and may help prevent complications:

• Eat a diet rich in fruits, vegetables, whole grains, and lean proteins to support immune function and healing.
• Include foods high in iron (e.g., spinach, red meat, lentils) to help replace blood lost during bleeding episodes.
• Stay hydrated to maintain healthy blood volume.
• Avoid excessive alcohol, as it can increase the risk of bleeding and liver damage (especially important if you've received plasma-derived factors in the past).

Emotional and Mental Health

Living with a chronic condition like hemophilia can be challenging. Consider the following:

• Join a support group (e.g., National Hemophilia Foundation) to connect with others who understand your experiences.
• Seek counseling or therapy if you feel overwhelmed, anxious, or depressed.
• Encourage open communication with your healthcare team about your concerns and goals.

Prevention

Since hemophilia is primarily a genetic disorder, it cannot be prevented. However, steps can be taken to reduce the risk of complications and bleeding episodes:

Preventing Bleeding Episodes

• Avoid activities with a high risk of injury (e.g., contact sports, rough play).
• Use protective equipment (e.g., helmets, padding) during physical activities.
• Childproof your home to prevent falls and injuries (e.g., secure rugs, install safety gates).
• Practice good oral hygiene to prevent dental issues that could lead to bleeding.
• Follow your prophylactic treatment plan as prescribed to prevent spontaneous bleeding.

Genetic Counseling

If you have a family history of hemophilia or are a known carrier, consider genetic counseling before starting a family. A genetic counselor can:

• Explain the inheritance pattern and risks to your children.
• Discuss options for prenatal testing or preimplantation genetic diagnosis (PGD) during in vitro fertilization (IVF).
• Provide support and resources for family planning decisions.

Complications

Without proper treatment, hemophilia can lead to serious complications, some of which can be life-threatening. Early intervention is key to preventing these issues.

Short-Term Complications

• Deep Internal Bleeding: Bleeding into muscles or organs can cause swelling, pain, and damage. For example, bleeding in the throat or neck can compress the airway, making it difficult to breathe.
• Compartment Syndrome: Severe bleeding into a muscle can increase pressure within the muscle compartment, compressing nerves and blood vessels. This requires emergency surgery to relieve the pressure.
• Hemorrhagic Shock: Significant blood loss can lead to a dangerous drop in blood pressure, depriving organs of oxygen. This is a medical emergency.

Long-Term Complications

• Joint Damage (Hemophilic Arthropathy): Repeated bleeding into joints can cause chronic inflammation, cartilage damage, and arthritis. This can lead to pain, stiffness, and reduced mobility.
• Chronic Pain: Due to joint damage or nerve compression from internal bleeding.
• Infections: People who received plasma-derived clotting factors before 1992 may have been exposed to viruses like HIV or hepatitis C. Modern treatments are much safer due to improved screening and recombinant factors.
• Inhibitor Development: As mentioned earlier, some people develop antibodies that attack clotting factors, making treatment less effective.
• Neurological Issues: Bleeding in the brain (intracranial hemorrhage) can cause headaches, seizures, paralysis, or even death. This is a rare but serious complication.

When to Seek Emergency Care

Additional Resources

• Centers for Disease Control and Prevention (CDC) - Hemophilia
• National Hemophilia Foundation
• World Federation of Hemophilia
• Mayo Clinic - Hemophilia
• National Heart, Lung, and Blood Institute (NHLBI) - Hemophilia